Stock listing
ABDX Stock Price, News, Filings & Events — Abingdon Health Plc
Selected listing: ABDX · LSE · GBX · GB
This page tracks Abingdon Health Plc's ABDX:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABDX:LSE. ABDX:LSE is the stock-level entry point for investors researching Abingdon Health Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abingdon Health Plc is a public company listed on the UK market under the ticker ABDX, with a market capitalization of approximately £33.2 million. The company specializes in the development and manufacturing of rapid diagnostic tests. Abingdon Health aims to improve healthcare outcomes through innovative testing solutions.

- Ticker
- ABDX:LSE
- Asset type
- Stock
- Market cap
- $37.9M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSE
- Currency
- GBX
Abingdon Health Plc ABDX:LSE stock context
This page tracks Abingdon Health Plc's ABDX:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABDX:LSE. ABDX:LSE is the stock-level entry point for investors researching Abingdon Health Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abingdon Health Plc is a public company listed on the UK market under the ticker ABDX, with a market capitalization of approximately £33.2 million. The company specializes in the development and manufacturing of rapid diagnostic tests. Abingdon Health aims to improve healthcare outcomes through innovative testing solutions.
Latest news from Abingdon Health Plc
Abingdon Health Plc earnings calls
ABINGDON HEALTH PLC (ABDX) — Interim Results
March 17, 2026 · Replay with transcript and chapters
ABINGDON HEALTH PLC (ABDX) — Preliminary results for the year ended 30 June 2025
November 11, 2025 · Replay with transcript and chapters
ABINGDON HEALTH PLC (ABDX) — Interim results for the six months ended 31 December 2024
March 26, 2025 · Replay with transcript and chapters
ABINGDON HEALTH PLC (ABDX) — Abingdon Health Full Year Results Presentation
October 8, 2024 · Replay with transcript and chapters
ABINGDON HEALTH PLC (ABDX) — Final Results for the year ended 30th June 2023
October 24, 2023 · Replay with transcript and chapters
Research Abingdon Health Plc
Abingdon Health Plc investor report
Review AI stock analysis and investor report context for ABDX:LSE.
Abingdon Health Plc company profile
View the public company page for Abingdon Health Plc on 6ix.
Abingdon Health Plc news
Read company news and market updates connected to Abingdon Health Plc.
Abingdon Health Plc investor events
Find investor webinars, events, and replay context for Abingdon Health Plc.